BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Topics
»
Disease categories and therapies
» Respiratory
Respiratory
RSS
Phase I trial of ETX-100 in hereditary pulmonary disorder initiated
Nov. 22, 2002
INS-37217 enters phase III trials for perennial allergic rhinitis
Nov. 22, 2002
Avanir presents novel compounds with IgE-modulatory and antiproliferative activity
Nov. 22, 2002
Series of PDE4 inhibitors in early development at Glenmark
Nov. 22, 2002
Altana and Tanabe Seiyaku to develop and commercialize roflumilast in Japan
Nov. 20, 2002
Inspire discontinues development of INS-365 Respiratory for chronic bronchitis
Nov. 20, 2002
Ortho-McNeil claims series of histamine H4 antagonists and their use in asthma
Nov. 19, 2002
Bayer presents novel p38 inhibitors for COPD
Nov. 19, 2002
Novel MMP inhibitors in AstraZeneca pipeline
Nov. 18, 2002
Omalizumab reported to be as safe as placebo in allergic asthma/rhinitis
Nov. 18, 2002
Previous
1
2
…
517
518
519
520
521
522
523
524
525
…
733
734
Next
RSS